Skoči na glavni sadržaj

Libri Oncologici : Croatian Journal of Oncology, Vol. 31 No. 1-3, 2003.

Ostalo

Acral melanoma – a report of 122 cases

Mladen Stanec ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Stjepan Juzbašić ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Miroslav Lesar ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Danko Velimir Vrdoljak ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Ivan Milas ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Nenad Nola ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Andrej Roth ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Dubravka Mužina ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia
Dubravka Krleža-Supić ; Department of Anesthesiology, University Hospital for Tumors, Zagreb,Croatia
Miroslav Banović ; Department of Transfusion Medicine and Hemostasis, University Hospital for Tumors, Zagreb, Croatia
Zrinko Petrinec ; Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia

Puni tekst: engleski pdf 79 Kb

str. 61-64

preuzimanja: 88

citiraj

Sažetak

The study includes 122 patients with acral melanoma (about 9.2% of all 1325 melanoma patients treated in the University Hospital for Tumors, Zagreb, Croatia from 1975 to 2002). Of them, there were 76 (62.3%) female and 46 (37.7%) male patients, with a mean age of 58 years. In 88 (72.1%) of the cases, the tumor was located on the legs and 34 (27.9%) of the patients had the tumor on the hands, of whom 15 (12.3%) under the nail plate. In the majority of cases, surgical treatment included wide excision of primary tumor and plastic reconstruction, or amputation in case of subungual melanoma. Dissection of clinically confirmed metastases in regional lymph nodes and sentinel node biopsy were performed in 35 (28.7%) and 2 (1.6%) of the patients, respectively. The five-year survival rate was 50% in stage I and II and 20% in stage III patients.

Ključne riječi

acral melanoma; surgical treatment; survival

Hrčak ID:

281798

URI

https://hrcak.srce.hr/281798

Datum izdavanja:

3.12.2003.

Podaci na drugim jezicima: hrvatski

Posjeta: 417 *